Metastatic Gastric Cancer Treatments Indicates Mixed Results Reporter: Irina Robu, PhD Two novel therapies for patients with metastatic gastric cancer were evaluated by Dr. David H. Ilson of Memorial Sloan Kettering Cancer Center in New York City. In one study, trifluridine/tipiracil (FTD/TPI) was revealed to be an effective treatment for patients with metastatic gastric cancer. […]
Original Article: Metastatic Gastric Cancer Treatments Indicates Mixed Results